IBDEI272 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36839,1,3,0)
 ;;=3^Mesothelioma of pleura
 ;;^UTILITY(U,$J,358.3,36839,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,36839,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,36840,0)
 ;;=C38.4^^169^1861^25
 ;;^UTILITY(U,$J,358.3,36840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36840,1,3,0)
 ;;=3^Malignant neoplasm of pleura
 ;;^UTILITY(U,$J,358.3,36840,1,4,0)
 ;;=4^C38.4
 ;;^UTILITY(U,$J,358.3,36840,2)
 ;;=^267140
 ;;^UTILITY(U,$J,358.3,36841,0)
 ;;=C41.9^^169^1861^16
 ;;^UTILITY(U,$J,358.3,36841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36841,1,3,0)
 ;;=3^Malignant neoplasm of bone and articular cartilage, unsp
 ;;^UTILITY(U,$J,358.3,36841,1,4,0)
 ;;=4^C41.9
 ;;^UTILITY(U,$J,358.3,36841,2)
 ;;=^5000993
 ;;^UTILITY(U,$J,358.3,36842,0)
 ;;=C49.9^^169^1861^19
 ;;^UTILITY(U,$J,358.3,36842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36842,1,3,0)
 ;;=3^Malignant neoplasm of connective and soft tissue, unsp
 ;;^UTILITY(U,$J,358.3,36842,1,4,0)
 ;;=4^C49.9
 ;;^UTILITY(U,$J,358.3,36842,2)
 ;;=^5001136
 ;;^UTILITY(U,$J,358.3,36843,0)
 ;;=C47.9^^169^1861^14
 ;;^UTILITY(U,$J,358.3,36843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36843,1,3,0)
 ;;=3^Malig neoplasm of prph nerves and autonm nervous sys, unsp
 ;;^UTILITY(U,$J,358.3,36843,1,4,0)
 ;;=4^C47.9
 ;;^UTILITY(U,$J,358.3,36843,2)
 ;;=^5001121
 ;;^UTILITY(U,$J,358.3,36844,0)
 ;;=C43.9^^169^1861^15
 ;;^UTILITY(U,$J,358.3,36844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36844,1,3,0)
 ;;=3^Malignant melanoma of skin, unspecified
 ;;^UTILITY(U,$J,358.3,36844,1,4,0)
 ;;=4^C43.9
 ;;^UTILITY(U,$J,358.3,36844,2)
 ;;=^5001015
 ;;^UTILITY(U,$J,358.3,36845,0)
 ;;=D03.9^^169^1861^29
 ;;^UTILITY(U,$J,358.3,36845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36845,1,3,0)
 ;;=3^Melanoma in situ, unspecified
 ;;^UTILITY(U,$J,358.3,36845,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,36845,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,36846,0)
 ;;=C44.01^^169^1861^5
 ;;^UTILITY(U,$J,358.3,36846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36846,1,3,0)
 ;;=3^Basal cell carcinoma of skin of lip
 ;;^UTILITY(U,$J,358.3,36846,1,4,0)
 ;;=4^C44.01
 ;;^UTILITY(U,$J,358.3,36846,2)
 ;;=^340464
 ;;^UTILITY(U,$J,358.3,36847,0)
 ;;=C44.02^^169^1861^35
 ;;^UTILITY(U,$J,358.3,36847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36847,1,3,0)
 ;;=3^Squamous cell carcinoma of skin of lip
 ;;^UTILITY(U,$J,358.3,36847,1,4,0)
 ;;=4^C44.02
 ;;^UTILITY(U,$J,358.3,36847,2)
 ;;=^340465
 ;;^UTILITY(U,$J,358.3,36848,0)
 ;;=C44.310^^169^1861^11
 ;;^UTILITY(U,$J,358.3,36848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36848,1,3,0)
 ;;=3^Basal cell carcinoma of skin of unspecified parts of face
 ;;^UTILITY(U,$J,358.3,36848,1,4,0)
 ;;=4^C44.310
 ;;^UTILITY(U,$J,358.3,36848,2)
 ;;=^5001043
 ;;^UTILITY(U,$J,358.3,36849,0)
 ;;=C44.311^^169^1861^6
 ;;^UTILITY(U,$J,358.3,36849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36849,1,3,0)
 ;;=3^Basal cell carcinoma of skin of nose
 ;;^UTILITY(U,$J,358.3,36849,1,4,0)
 ;;=4^C44.311
 ;;^UTILITY(U,$J,358.3,36849,2)
 ;;=^5001044
 ;;^UTILITY(U,$J,358.3,36850,0)
 ;;=C44.319^^169^1861^7
 ;;^UTILITY(U,$J,358.3,36850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36850,1,3,0)
 ;;=3^Basal cell carcinoma of skin of other parts of face
 ;;^UTILITY(U,$J,358.3,36850,1,4,0)
 ;;=4^C44.319
 ;;^UTILITY(U,$J,358.3,36850,2)
 ;;=^5001045
 ;;^UTILITY(U,$J,358.3,36851,0)
 ;;=C44.320^^169^1861^42
 ;;^UTILITY(U,$J,358.3,36851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36851,1,3,0)
 ;;=3^Squamous cell carcinoma of skin of unspecified parts of face
 ;;^UTILITY(U,$J,358.3,36851,1,4,0)
 ;;=4^C44.320
